Julie C. Locklear v. Argenx US, Inc.

CourtMassachusetts Appeals Court
DecidedFebruary 20, 2025
Docket24-P-0184
StatusUnpublished

This text of Julie C. Locklear v. Argenx US, Inc. (Julie C. Locklear v. Argenx US, Inc.) is published on Counsel Stack Legal Research, covering Massachusetts Appeals Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Julie C. Locklear v. Argenx US, Inc., (Mass. Ct. App. 2025).

Opinion

NOTICE: Summary decisions issued by the Appeals Court pursuant to M.A.C. Rule 23.0, as appearing in 97 Mass. App. Ct. 1017 (2020) (formerly known as rule 1:28, as amended by 73 Mass. App. Ct. 1001 [2009]), are primarily directed to the parties and, therefore, may not fully address the facts of the case or the panel's decisional rationale. Moreover, such decisions are not circulated to the entire court and, therefore, represent only the views of the panel that decided the case. A summary decision pursuant to rule 23.0 or rule 1:28 issued after February 25, 2008, may be cited for its persuasive value but, because of the limitations noted above, not as binding precedent. See Chace v. Curran, 71 Mass. App. Ct. 258, 260 n.4 (2008).

COMMONWEALTH OF MASSACHUSETTS

APPEALS COURT

24-P-184

JULIE C. LOCKLEAR

vs.

ARGENX US, INC.

MEMORANDUM AND ORDER PURSUANT TO RULE 23.0

The plaintiff, Julie C. Locklear, filed a complaint against

the defendant, her former employer argenx US, Inc., asserting

employment discrimination on the basis of disability or being

regarded as a person with a disability. A judge of the Superior

Court granted argenx summary judgment, concluding Locklear

failed to "demonstrate or introduce questions of fact by way of

direct or circumstantial evidence" that argenx's

nondiscriminatory reasons for terminating Locklear were

pretextual (emphasis omitted). We affirm.

Background. We summarize the material facts in the light

most favorable to Locklear with additional facts reserved for

later discussion. In September 2019, argenx, a pharmaceutical company based in Belgium and with an office in Boston, hired

Locklear as head of health economics and outcomes research.

While Locklear was based in argenx's Boston office, her

supervisor, Trevor Leighton, was based in Belgium. Leighton and

Locklear's working relationship began on a positive note. For

instance, argenx's chief operating officer (COO), Robert Keith

Woods, reported that Leighton was Locklear's "biggest fan in the

company" on her hire. Leighton was complimentary and

"impressed" by Locklear's work product during the first few

months after her hire.

In early January of 2020, Locklear informed Leighton that

she suffered from hypersomnia.1 Locklear did not state either

that she had a disability or that the condition would impact her

work performance. In response, Leighton told Locklear that she

"cannot use [her] disability as an excuse not to deliver" and

"[she has] to come up with strategies to overcome it." In mid-

January, Leighton met with argenx's head of human resources,

Sara Mannle, to discuss how to improve his working relationship

with Locklear. At this meeting, Leighton expressed concerns

about Locklear's understanding of his expectations and the

quality of her work. On January 20, Leighton communicated this

displeasure to Locklear by telling her that slides she had

1 Hypersomnia is a condition characterized by excessive daytime sleepiness.

2 created were "far from what [they] discussed and [he]

envisaged."

On February 6, Locklear described her hypersomnia to

Leighton as a "disability." Leighton notified Mannle. On the

same day, Locklear spoke to Mannle and "made some claims about

mistreatment" by Leighton and "expressed concerns about

Leighton's management style." On February 10, Mannle and Julia

Dumaux, argenx's human resources business partner, met with

Locklear to discuss her concerns. On February 11, Locklear

again met with Dumaux, where she stated that Leighton was "not

used to working with a strong woman" and did not understand

"some of the projects she [was] working on." On the same day,

Mannle sent an e-mail message to Leighton informing him of

Locklear's concerns and provided him feedback on improving his

relationship with Locklear. On February 13, Mannle met with

Locklear and Leighton, and following the meeting, provided

feedback to both of them on improving their communication.

On February 25, Locklear wrote an e-mail message to Mannle

and requested that she no longer be required to report directly

to Leighton. Locklear wrote, "[Leighton], therefore argenx, is

making me ill. I go home every day not believing in myself, my

work and whether or not I should even stay with argenx. This

has taken a toll on me professionally and personally. . . . I

am dealing with a personal illness." Later that day, Locklear

3 wrote an e-mail message to Leighton informing him she would not

be attending their scheduled one-on-one meeting the following

day, nor would she be attending any future one-on-one meetings

with him. In response, Mannle wrote to Locklear, stating "it is

not ok to just decline this meeting and more importantly future

meetings," and suggesting the three of them meet the following

day. Locklear then requested a meeting with Mannle and Woods,

indicating she was free to meet the following day. In response,

Mannle again suggested Locklear, Leighton, and herself meet.

Woods also responded, that he was willing to meet and "committed

to help."

On the following day, Locklear did not attend a scheduled

meeting with Mannle and Leighton. Locklear also failed to

attend the meeting she had requested with Mannle and Woods.

Mannle attempted to reach Locklear by calling and sending text

messages to her; Locklear did not respond. On or about February

26, Mannle and Woods discussed Locklear's actions and decided to

terminate her. On February 27, Mannle wrote Locklear an e-mail

message informing her that she was terminated and articulating

argenx's reasons for the decision. Locklear did not respond to

this message.

Discussion. 1. Standard of review. On appeal, "[w]e

review a grant of summary judgment de novo." Miller v. Cotter,

448 Mass. 671, 676 (2007). "We view the evidence in the light

4 most favorable to the nonmoving party." Federal Nat'l Mtge.

Ass'n v. Hendricks, 463 Mass. 635, 637 (2012). "Summary

judgment is appropriate where there is no material issue of fact

in dispute, and the moving party is entitled to judgment as a

matter of law." Berry v. Commerce Ins. Co., 488 Mass. 633, 636

(2021). Summary judgment is "a disfavored remedy in the context

of discrimination cases based on disparate treatment . . .

because the ultimate issue of discriminatory intent is a factual

question" (citation omitted). Bulwer v. Mount Auburn Hosp., 473

Mass. 672, 689 (2016).

2. McDonnell Douglas framework. General Laws c. 151B,

§ 4 (16), bars employment discrimination on the basis of

disability or perceived disability:

"It shall be an unlawful practice . . . [f]or any employer, personally or through an agent, to dismiss from employment or refuse to hire, rehire or advance in employment or otherwise discriminate against, because of . . . handicap, any person alleging to be a qualified handicapped person, capable of performing the essential functions of the position involved with reasonable accommodation."2

To survive summary judgment on a claim brought under this

provision, "an employee-plaintiff must produce evidence from

which a reasonable jury may infer 'four elements: membership in

a protected class, harm, discriminatory animus, and causation'"

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Staub v. Proctor Hospital
131 S. Ct. 1186 (Supreme Court, 2011)
Bonefont-Igaravidez v. International Shipping Corp.
659 F.3d 120 (First Circuit, 2011)
Bennett v. Saint-Gobain Corp.
507 F.3d 23 (First Circuit, 2007)
Ponte v. Steelcase Inc.
741 F.3d 310 (First Circuit, 2014)
Bulwer v. Mount Auburn Hospital
46 N.E.3d 24 (Massachusetts Supreme Judicial Court, 2016)
Verdrager v. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
50 N.E.3d 778 (Massachusetts Supreme Judicial Court, 2016)
Tate v. Department of Mental Health
645 N.E.2d 1159 (Massachusetts Supreme Judicial Court, 1995)
Sullivan v. Liberty Mutual Insurance
825 N.E.2d 522 (Massachusetts Supreme Judicial Court, 2005)
Miller v. Cotter
448 Mass. 671 (Massachusetts Supreme Judicial Court, 2007)
Federal National Mortgage Ass'n v. Hendricks
977 N.E.2d 552 (Massachusetts Supreme Judicial Court, 2012)
Chace v. Curran
881 N.E.2d 792 (Massachusetts Appeals Court, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
Julie C. Locklear v. Argenx US, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/julie-c-locklear-v-argenx-us-inc-massappct-2025.